HUMAN-IMMUNODEFICIENCY-VIRUS STRUCTURE - IMPLICATIONS FOR ANTIVIRAL DESIGN

被引：0

作者：

ARNOLD, E ^{[1
]}

ARNOLD, GF ^{[1
]}

机构：

[1] RUTGERS STATE UNIV, DEPT CHEM, PISCATAWAY, NJ 08854 USA

来源：

ADVANCES IN VIRUS RESEARCH | 1991年 / 39卷

关键词：

D O I：

暂无

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：1 / 87

页数：87

共 50 条

[1] ANTIVIRAL THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTIONS
DECLERCQ, E
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (02) : 200 - 239
[2] ANTIVIRAL CHEMOTHERAPY FOR INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS
POLSKY, B
REVIEWS OF INFECTIOUS DISEASES, VOL 11, SUPPL 7: CONTROVERSIES IN THE MANAGEMENT OF INFECTIOUS COMPLICATIONS OF NEOPLASTIC DISEASES, 1989, : S1648 - S1663
[3] ANTIVIRAL THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN CHILDREN
MCKINNEY, RE
PEDIATRIC CLINICS OF NORTH AMERICA, 1991, 38 (01) : 133 - 151
[4] ANTIVIRAL EFFECT OF PHOSPHOROTHIOATE OLIGODEOXYRIBONUCLEOTIDES COMPLEMENTARY TO HUMAN-IMMUNODEFICIENCY-VIRUS
KIM, SG
HATTA, T
TSUKAHARA, S
NAKASHIMA, H
YAMAMOTO, N
SHOJI, Y
TAKAI, K
TAKAKU, H
BIOORGANIC & MEDICINAL CHEMISTRY, 1995, 3 (01) : 49 - 54
[5] THE HUMAN-IMMUNODEFICIENCY-VIRUS TAT PROTEIN - A TARGET FOR ANTIVIRAL AGENTS
SIM, IS
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 616 : 64 - 72
[6] REGULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - IMPLICATIONS FOR PATHOGENESIS
ANTONI, BA
STEIN, SB
RABSON, AB
ADVANCES IN VIRUS RESEARCH, VOL 43, 1994, 43 : 53 - 145
[7] SOYBEAN SAPONIN AND ISOFLAVONOIDS - STRUCTURE AND ANTIVIRAL ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS IN-VITRO
OKUBO, K
KUDOU, S
UCHIDA, T
YOSHIKI, Y
YOSHIKOSHI, M
TONOMURA, M
FOOD PHYTOCHEMICALS FOR CANCER PREVENTION I: FRUITS AND VEGETABLES, 1994, 546 : 330 - 339
[8] HUMAN-IMMUNODEFICIENCY-VIRUS
PHILLIPS, DM
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04): : 233 - 233
[9] HUMAN-IMMUNODEFICIENCY-VIRUS
BROWN, F
SCIENCE, 1986, 232 (4757) : 1486 - 1486
[10] HUMAN-IMMUNODEFICIENCY-VIRUS
不详
WIENER MEDIZINISCHE WOCHENSCHRIFT, 1992, 142 (13) : A1 - A8

← 1 2 3 4 5 →